1. |
Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol, 2017, 69(10): 1215-1230.
|
2. |
Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med, 2020, 383(15): 1447-1457.
|
3. |
Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, et al. Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2016, 9(16): 1706-1717.
|
4. |
Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med, 2020, 382(18): 1696-1707.
|
5. |
Muller Moran HR, Eikelboom R, Lodewyks C. Two-year outcomes from the PARTNER 3 trial: Where do we stand? Curr Opin Cardiol, 2020 [Epub ahend of print].
|
6. |
Writing Committee Members, Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive Summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 [Epub ahend of print].
|
7. |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
|
8. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
9. |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020更新版). 中国介入心脏病学杂志, 2020, 28(6): 301-309.
|
10. |
Chakravarty T, Makar M, Patel D, et al. Transcatheter edge-to-edge mitral valve repair with the MitraClip G4 system. JACC Cardiovasc Interv, 2020, 13(20): 2402-2414.
|
11. |
Praz F, Braun D, Unterhuber M, et al. Edge-to-edge mitral valve repair with extended clip arms: Early experience from a multicenter observational study. JACC Cardiovasc Interv, 2019, 12(14): 1356-1365.
|
12. |
韩治伟, 周益锋, 郑金刚. 医源性房间隔缺损的研究进展. 中华心律失常学杂志, 2020, 24(5): 520-523.
|
13. |
Morikawa T, Miyasaka M, Flint N, et al. Right-to-left shunt through iatrogenic atrial septal defect after MitraClip procedure. JACC Cardiovasc Interv, 2020, 13(13): 1544-1553.
|
14. |
Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: The first 100 patients. J Am Coll Cardiol, 2019, 73(11): 1250-1260.
|
15. |
Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol, 2018, 71(1): 12-21.
|
16. |
Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet, 2019, 394(10213): 2002-2011.
|
17. |
Fam NP, Braun D, von Bardeleben RS, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: A multicenter, observational, first-in-human experience. JACC Cardiovasc Interv, 2019, 12(24): 2488-2495.
|
18. |
Pan W, Zhou D, Wu Y, et al. First-in-human results of a novel user-friendly transcatheter edge-to-edge mitral valve repair device. JACC Cardiovasc Interv, 2019, 12(23): 2441-2443.
|
19. |
Lu FL, Ma Y, An Z, et al. First-in-man experience of transcatheter tricuspid valve replacement with LuX-Valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv, 2020, 13(13): 1614-1616.
|
20. |
Song G, Pan W, Zhou D, et al. 2019 China Structure Week. Eur Heart J, 2020, 41(13): 1325-1327.
|